ONCOLOGY IMPACT FUND Trademark

Trademark Overview

On Sunday, January 20, 2019, a trademark application was filed for ONCOLOGY IMPACT FUND with the United States Patent and Trademark Office. The USPTO has given the ONCOLOGY IMPACT FUND trademark a serial number of 88268830. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by MPM Oncology Impact Management LP. The ONCOLOGY IMPACT FUND trademark is filed in the Insurance & Financial Services category with the following description:

Financial services, namely, investment advice, investment management, investment consultation and investment of funds for others, including private and public equity and debt investment services; Venture capital financing; Venture capital fund management
oncology impact fund

General Information

Serial Number88268830
Word MarkONCOLOGY IMPACT FUND
Filing DateSunday, January 20, 2019
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6160299
Registration DateTuesday, September 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 1, "Oncology Impact Management, Inc. (MASSACHUSETTS CORPORATION)" should be deleted, and "MPM Oncology Impact Management LP (DELAWARE LIMITED PARTNERSHIP)" should be inserted.
Goods and ServicesFinancial services, namely, investment advice, investment management, investment consultation and investment of funds for others, including private and public equity and debt investment services; Venture capital financing; Venture capital fund management
NOT AVAILABLE"IMPACT FUND"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 12, 2019
Primary Code036
First Use Anywhere DateTuesday, May 3, 2016
First Use In Commerce DateTuesday, May 3, 2016

Trademark Owner History

Party NameMPM BIOIMPACT LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBOSTON, MA 02116
Party NameMPM Oncology Impact Management LP
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressCambridge, MA 02142
Party NameMPM Oncology Impact Management LP
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, January 23, 2019NEW APPLICATION ENTERED
Tuesday, February 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 1, 2019ASSIGNED TO EXAMINER
Tuesday, April 9, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 9, 2019NON-FINAL ACTION E-MAILED
Tuesday, April 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 6, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, November 6, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, December 26, 2019TEAS PETITION TO REVIVE RECEIVED
Thursday, December 26, 2019PETITION TO REVIVE-GRANTED
Thursday, December 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 27, 2019NOTICE OF REVIVAL - E-MAILED
Wednesday, January 15, 2020ASSIGNED TO LIE
Wednesday, January 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 3, 2020FINAL REFUSAL WRITTEN
Monday, February 3, 2020FINAL REFUSAL E-MAILED
Monday, February 3, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 31, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, July 31, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 31, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 12, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, August 19, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 22, 2020REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, November 17, 2020TEAS SECTION 7 REQUEST RECEIVED
Wednesday, January 20, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 5, 2021CORRECTION UNDER SECTION 7 - PROCESSED
Wednesday, November 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, September 22, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

fund impact oncology investment capital management venture services equity debt financing public